T-24 Donor-related characteristics as predictors of sustained virologic response to antiviral therapy in recurrent hepatitis C after liver transplantation
✍ Scribed by R.M. Iemmolo; M. Marino; R. Montalti; F. Ponziani; R. Viganò; E. De Martin; M.F. Donato; M. Rendina; M. Cescon; D. Di Paolo; E. Fornasiere; L. Miglioresi; V. Giannelli; S. Fagiuoli; G.E. Gerunda
- Book ID
- 119634355
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 48 KB
- Volume
- 43
- Category
- Article
- ISSN
- 1590-8658
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Factors associated with sustained virological response (SVR) in patients treated for hepatitis C virus (HCV) recurrence after liver transplantation (LT) are unclear. Ninety-nine HCV-positive/hepatitis B surface antigen-negative patients received antiviral treatment (AVT) with interferon/peginterfero
Sustained virologic response (SVR) after antiviral therapy for recurrent hepatitis C virus (HCV) infection in liver transplant (LT) recipients is consistently lower than that achieved in non-LT patients. We evaluated efficacy and safety of pegylated interferon (IFN) and ribavirin (RBV) therapy in LT